PR-104

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NamePR-104
Drug Alias NameSN-29244PR-104
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlkylating agents
TargetsDNA
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungLung Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSingapore +[6] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesProacta Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProacta Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungLung Neoplasms +[6] 

Other Information

ATC CodeN/A
Related LinksWikipedia